Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Maertens

Mycoses

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Mycoses|October 10, 2015
Burden of serious fungal infections in BelgiumKatrien Lagrou, Johan Maertens, Ellen Van Even, et al.
Mycoses|March 31, 2007
Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disordersJohan Maertens, Koen Theunissen, Tom Lodewyck, et al.
Mycoses|July 18, 2019
Gliotoxin and bis(methylthio)gliotoxin are not reliable as biomarkers of invasive aspergillosisToine Mercier, Agustin Reséndiz Sharpe, Dieter Waumans, et al.
Mycoses|October 13, 2017
Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungalsBerdieke Goemaere, Pierre Becker, Eric Van Wijngaerden, et al.
Mycoses|November 3, 2010
Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould diseaseOliver A Cornely, Johan Maertens, Mark Bresnik, et al.
Mycoses|May 14, 2026
Impact of Concomitant Metamizole Treatment on the Exposure of Mould-Active TriazolesDorian Vanneste, Ine De Booser, Kristina Nadrah, et al.
Mycoses|July 24, 2018
Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazoleJohan Maertens, Dominik Selleslag, Werner J Heinz, et al.
Mycoses|February 4, 2020
Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM surveyFanny Lanternier, Danila Seidel, Livio Pagano, et al.
Mycoses|March 18, 2020
European confederation of medical mycology expert consult-An ECMM excellence center initiativePhilipp Koehler, Blandine Denis, David W Denning, et al.
Mycoses|November 15, 2018
Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) projectMatteo Bassetti, Luigia Scudeller, Daniele R Giacobbe, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Mycoses|October 10, 2015
Burden of serious fungal infections in BelgiumKatrien Lagrou, Johan Maertens, Ellen Van Even, et al.
Mycoses|March 31, 2007
Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disordersJohan Maertens, Koen Theunissen, Tom Lodewyck, et al.
Mycoses|July 18, 2019
Gliotoxin and bis(methylthio)gliotoxin are not reliable as biomarkers of invasive aspergillosisToine Mercier, Agustin Reséndiz Sharpe, Dieter Waumans, et al.
Mycoses|October 13, 2017
Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungalsBerdieke Goemaere, Pierre Becker, Eric Van Wijngaerden, et al.
Mycoses|November 3, 2010
Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould diseaseOliver A Cornely, Johan Maertens, Mark Bresnik, et al.
Mycoses|May 14, 2026
Impact of Concomitant Metamizole Treatment on the Exposure of Mould-Active TriazolesDorian Vanneste, Ine De Booser, Kristina Nadrah, et al.
Mycoses|July 24, 2018
Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazoleJohan Maertens, Dominik Selleslag, Werner J Heinz, et al.
Mycoses|February 4, 2020
Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM surveyFanny Lanternier, Danila Seidel, Livio Pagano, et al.
Mycoses|March 18, 2020
European confederation of medical mycology expert consult-An ECMM excellence center initiativePhilipp Koehler, Blandine Denis, David W Denning, et al.
Mycoses|November 15, 2018
Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) projectMatteo Bassetti, Luigia Scudeller, Daniele R Giacobbe, et al.
Pageof 1